Danila Comandini Fabio Catalano Massimiliano Grassi Guido Pesola Rossella Bertulli Antonio Guadagno Bruno Spina Matteo Mascherini Franco De Cian Federico Pistoia Sara Elena Rebuzzi
10.3389/fonc.2021.658327
Front Oncol
2021 Jun 15;11:658327.
ros1 crizotinib inflammatory myofibroblastic tumor inflammatory pseudotumor retreatment sarcoma target therapy
CC BY
https://pubmed.ncbi.nlm.nih.gov/34211840/
Case Reports
PMC8239351
34211840
Outstanding Response in a Patient With ROS1-Rearranged Inflammatory Myofibroblastic Tumor of Soft Tissues Treated With Crizotinib: Case Report
2021